MedTrace Logo

Spanish Validation Of Quality of Life Questionnaire (QOLIE-10) For Epilepsy

NCT00264680 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 333

Last updated 2017-10-30

No results posted yet for this study

Summary

Validation of qolie-10, an epilepsy specific quality of life questionnaire in patients treated with lamotrigine or valproic acid. Comparison of quality of life of epileptic patients treated with lamotrigine or valproic acid. Determination and assessment of the comparative safety of lamotrigine or valproic acid. Assessment and comparison of body image perception in women treated with lamotrigine or valproic acid.

Conditions

Interventions

DRUG

lamotrigine

DRUG

valproic acid

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-01
Primary Completion
2006-03-01
Completion
2006-03-01

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00264680 on ClinicalTrials.gov